M. Udoh

Cannabichromene is a cannabinoid CB2 receptor agonist

I. McGregor, M. Connor, Marina Santiago, 2018, bioRxiv.

Cannabichromene is a cannabinoid CB2 receptor agonist

I. McGregor, M. Connor, Marina Santiago, 2018, bioRxiv.

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels

C. Bladen, I. McGregor, J. Arnold, 2022, Frontiers in Pharmacology.

Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome

I. McGregor, J. Arnold, L. Anderson, 2022, Journal of Cannabis Research.

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy

J. Howland, C. Bladen, I. McGregor, 2023, Frontiers in Physiology.

Activation of cannabinoid CB2 receptors by (−)-cannabichromene but not (+)-cannabichromene

P. Barr, M. Connor, C. Marlowe, 2023, bioRxiv.